You’re cruising through a cardio pharm block and hit a question that looks like it’s about “which diuretic?”—but it’s really about mechanism, electrolytes, hemodynamics, and side effects. Loop diuretics are a USMLE staple because they show up in CHF, pulmonary edema, hypercalcemia, and drug toxicity vignettes—and the distractors are almost always “near-miss” diuretics or RAAS drugs with overlapping clinical uses.
Tag: Cardiovascular > Cardiac Pharmacology
The Clinical Vignette (Q-bank style)
A 68-year-old man with a history of systolic heart failure (HFrEF) and hypertension presents with acute shortness of breath. He is tachypneic and hypoxic. Exam shows diffuse crackles, elevated JVP, and 2+ pitting edema. Chest X-ray demonstrates pulmonary edema. He is given an IV medication that leads to rapid symptomatic improvement. Shortly afterward, labs show:
- Na⁺ 138 mEq/L
- K⁺ 2.9 mEq/L
- Cl⁻ 96 mEq/L
- HCO₃⁻ 34 mEq/L
- Mg²⁺ low
Which drug was most likely administered?
Answer choices:
A. Furosemide
B. Hydrochlorothiazide
C. Spironolactone
D. Acetazolamide
E. Mannitol
Step-by-step: Why the Correct Answer is Furosemide (A)
The clinical “tell”
This is acute decompensated heart failure with pulmonary edema. The phrase “IV medication” + “rapid symptomatic improvement” is a classic clue for IV loop diuretics.
Mechanism (must-know)
Loop diuretics (furosemide, bumetanide, torsemide, ethacrynic acid) inhibit the:
- Na⁺-K⁺-2Cl⁻ (NKCC2) cotransporter in the thick ascending limb of the loop of Henle.
This segment is water-impermeable and is a huge driver of medullary hypertonicity. Blocking NKCC2 causes powerful natriuresis/diuresis → decreased intravascular volume.
The lab pattern
Loop diuretics commonly cause:
- Hypokalemic metabolic alkalosis
- Here: K⁺ low and HCO₃⁻ high
- Hypomagnesemia
- Increased Ca²⁺ excretion (loops “lose Ca²⁺”)
The immediate hemodynamic benefit
A classic high-yield pearl: IV loop diuretics also cause venodilation (via prostaglandins) → reduced preload quickly, which helps pulmonary edema even before major diuresis kicks in.
USMLE tie-in: If they mention NSAID use blunting the effect, that’s because NSAIDs ↓ prostaglandins → ↓ loop diuretic efficacy.
High-yield Loop Diuretic Facts (memorize-friendly)
Core effects
- ↑ Na⁺, K⁺, Cl⁻, Mg²⁺ excretion
- ↑ Ca²⁺ excretion (treat hypercalcemia)
- ↑ urine output (most potent diuretics)
Indications you’ll see in vignettes
- Acute pulmonary edema (IV)
- CHF with volume overload
- Edema (cirrhosis, nephrotic syndrome)
- Hypercalcemia
- Sometimes for HTN when GFR is low (thiazides less effective)
Toxicities (the “OHH DANG” set)
| Adverse effect | Why it happens / clue |
|---|---|
| Ototoxicity | dose-related; more likely with aminoglycosides |
| Hypokalemia | increased distal Na⁺ delivery → ↑ K⁺ secretion |
| Hypomagnesemia | loss of lumen-positive potential |
| Dehydration | overdiuresis |
| Allergy (sulfa) | furosemide/bumetanide/torsemide are sulfonamides |
| Nephritis (AIN) | uncommon but tested |
Ethacrynic acid is the loop diuretic to remember when they say: “severe sulfa allergy.” (Also ototoxic.)
Now Destroy the Distractors (B–E)
B. Hydrochlorothiazide — tempting, but wrong for acute pulmonary edema
Why it might lure you: thiazides are diuretics used for hypertension and mild edema.
Why it’s wrong here:
- Thiazides are less potent and not the go-to for acute pulmonary edema.
- Mechanism: blocks Na⁺/Cl⁻ cotransporter in the distal convoluted tubule.
High-yield contrast: loops vs thiazides
- Loops: “lose Ca²⁺” (↑ Ca²⁺ excretion)
- Thiazides: “save Ca²⁺” (↓ Ca²⁺ excretion) → can cause hypercalcemia
Thiazide side effects you should recognize:
- Hyponatremia
- Hypokalemic metabolic alkalosis (yes, also!)
- HyperGLUC: HyperGlycemia, HyperLipidemia, HyperUricemia, HyperCalcemia
So if the vignette screamed recurrent calcium kidney stones and they want prevention: that’s when HCTZ becomes attractive.
C. Spironolactone — wrong timeline and wrong electrolyte direction
Why it might lure you: it’s used in HF, improves mortality, and is a “diuretic.”
Why it’s wrong here:
- Not used for rapid symptom relief in acute pulmonary edema.
- Causes hyperkalemia (this patient has hypokalemia).
- Much weaker diuresis than loops.
Mechanism:
- Aldosterone receptor antagonist in the collecting duct → ↓ ENaC and Na⁺ reabsorption → ↓ K⁺/H⁺ secretion.
USMLE HF pearl:
- Spironolactone/eplerenone are mortality-benefit drugs in HFrEF (along with ACEi/ARB/ARNI, beta blockers, SGLT2 inhibitors, hydralazine/isosorbide dinitrate in select patients).
- Tested adverse effect: gynecomastia (spironolactone); eplerenone is more selective.
D. Acetazolamide — wrong acid-base pattern
Why it might lure you: it’s a diuretic and changes bicarbonate.
Why it’s wrong here:
- Acetazolamide causes metabolic acidosis (loss of HCO₃⁻), not alkalosis.
- It’s not the go-to for pulmonary edema volume removal.
Mechanism:
- Carbonic anhydrase inhibitor in the proximal tubule → ↓ HCO₃⁻ reabsorption → alkaline urine, acidic blood.
Classic indications:
- Altitude sickness
- Glaucoma
- Idiopathic intracranial hypertension
- Metabolic alkalosis correction (sometimes)
Side effects to recall:
- NAGMA metabolic acidosis
- Hypokalemia
- Kidney stones (↑ urine pH)
- Sulfa allergy risk
E. Mannitol — would worsen pulmonary edema
Why it might lure you: osmotic diuretic, increases urine output.
Why it’s wrong here:
- Mannitol initially expands intravascular volume by pulling water into the bloodstream → can worsen pulmonary edema and CHF.
- It’s used more for reducing intracranial pressure and intraocular pressure.
Mechanism:
- Osmotic diuretic filtered at the glomerulus, not reabsorbed → holds water in the tubule.
Board-style contraindication clue:
- If the patient has CHF or pulmonary edema, mannitol is dangerous.
The “Answer Choice Matters” Takeaways (what to remember on test day)
If you see acute pulmonary edema in CHF
Think:
- IV loop diuretic (e.g., furosemide) for rapid decongestion
- Expect hypokalemic metabolic alkalosis and hypomagnesemia
If you see recurrent calcium stones
Think:
- Thiazide (↓ urinary Ca²⁺)
If you see HFrEF mortality benefit + hyperK risk
Think:
- Spironolactone/eplerenone
If you see altitude sickness / glaucoma / IIH
Think:
- Acetazolamide (metabolic acidosis)
If you see increased ICP but NOT CHF
Think:
- Mannitol (watch for pulmonary edema)
Rapid-Fire Table: Diuretics at a Glance (USMLE favorite)
| Drug class | Site | Acid-base | K⁺ effect | Signature clinical clue |
|---|---|---|---|---|
| Loop (furosemide) | Thick ascending limb (NKCC2) | Metabolic alkalosis | ↓ K⁺ | Pulmonary edema, hypercalcemia, ototoxicity |
| Thiazide (HCTZ) | DCT (Na⁺/Cl⁻) | Metabolic alkalosis | ↓ K⁺ | Hypercalcemia, gout, hyperglycemia |
| K⁺-sparing (spironolactone) | Collecting duct | Mild acidosis tendency | ↑ K⁺ | Gynecomastia, mortality benefit in HFrEF |
| CA inhibitor (acetazolamide) | PCT | Metabolic acidosis | ↓ K⁺ | Altitude sickness, glaucoma, kidney stones |
| Osmotic (mannitol) | PCT/descending limb | Variable | Variable | ↑ ICP/IOP; worsens CHF/pulm edema |